NW Bio granted cell production patent

Northwest Biotherapeutics Inc., of Bethesda, a biotechnology company developing personalized immune therapies for solid tumor cancers, announced that it has been issued a U.S. patent covering novel processes for manufacturing human dendritic cells.

Leave a Reply

Your email address will not be published. Required fields are marked *